Carolina Zampirolli Dias

ORCID: 0000-0003-2181-4268
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmaceutical Economics and Policy
  • Public Health in Brazil
  • Pharmaceutical industry and healthcare
  • Vaccine Coverage and Hesitancy
  • Health, Nursing, Elderly Care
  • COVID-19 Impact on Reproduction
  • Chronic Lymphocytic Leukemia Research
  • Corneal Surgery and Treatments
  • Women's cancer prevention and management
  • Economic and Financial Impacts of Cancer
  • Bacterial Infections and Vaccines
  • Healthcare Regulation
  • Parkinson's Disease and Spinal Disorders
  • Media and Communication Studies
  • Maternal and Neonatal Healthcare
  • Palliative and Oncologic Care
  • Respiratory viral infections research
  • Pregnancy and Medication Impact
  • Environmental and biological studies
  • HER2/EGFR in Cancer Research
  • Youth, Drugs, and Violence
  • Medical Malpractice and Liability Issues
  • Health Education and Validation
  • Pneumonia and Respiratory Infections

Universidade Federal de Minas Gerais
2017-2025

Introduction: There are growing concerns among European health authorities regarding increasing prices for new cancer medicines, not necessarily linked to gain and the implications sustainability of their healthcare systems.Areas covered: Narrative discussion principally payers advisers potential approaches pricing medicines.Expert opinion: A number discussed including minimum effectiveness levels managed entry agreements, multicriteria decision analyses (MCDAs), differential/tiered pricing,...

10.1080/14737167.2021.1884546 article EN cc-by-nc-nd Expert Review of Pharmacoeconomics & Outcomes Research 2021-02-05

OBJECTIVE: To evaluate the access to medicines in primary health care of Brazilian Unified Health System (SUS), from patients’ perspective. METHODS: This is a cross-sectional study that used data Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos – Services, 2015 (PNAUM National Survey on Access, Use and Promotion Rational Medicines), conducted by interviews with 8,591 patients cities five regions Brazil. Evaluation concepts proposed Penshansky Thomas...

10.11606/s1518-8787.2017051007139 article EN cc-by Revista de Saúde Pública 2017-09-22

This study analyzed breast cancer patients treated with trastuzumab in Brazil's unified health system (SUS) from 2008 to 2015. A non-concurrent cohort using SUS data applied propensity score matching reduce bias between and non-trastuzumab groups. Survival probabilities were estimated via Kaplan-Meier, subgroup analysis the log-rank test. Hazard ratios (HR) calculated Cox proportional hazards models. Among 20,852 patients, overall survival rate was 92%, 94% group 90% group. Younger, black...

10.1038/s41598-025-88575-3 article EN cc-by-nc-nd Scientific Reports 2025-02-12

Background By the fact that pregnant and postpartum women are currently using COVID-19 vaccines, ensure their safety is critical. So, more evidence crucial to include this new technology vaccine’s calendar develop public policies regarding support training of Health Care Personnel. This study aims describe adverse events (AE) vaccines in early stage vaccination campaign Brazil. Methods An observational cross-sectional data from Brazilian surveillance information system characterize AE...

10.1371/journal.pone.0280284 article EN cc-by PLoS ONE 2023-01-13

The pneumococcal conjugate vaccination (PCV) was introduced into the Brazilian Childhood National Immunization Program in 2010; however, universal for older adults has not been implemented yet. Our aim is to evaluate trends meningitis incidence and case fatality rate (CFR) across all age groups from 2007 2019 using data Surveillance System. pre-PCV (2007–2009) post-PCV (2011–2019) periods were compared; changes CFR assessed by joinpoint regression. Additional analyses of bacterial performed...

10.3390/vaccines11081279 article EN cc-by Vaccines 2023-07-25

Sustainability and the ability to maintain right health, with guarantee of access quality medicines health services, have been a great challenge for countries universal systems. The technological advances bring it an expressive increase in expenditures systems, especially those directed towards acquisition high-cost drugs, which are still under patent protection, high cost and, some cases, present uncertainties about their effectiveness safety. As way maintaining proper functioning systems...

10.1186/s12939-019-0916-3 article EN cc-by International Journal for Equity in Health 2019-06-02

Abstract Background Although COVID-19 vaccines are currently under use in pregnant and postpartum women, there is still lack of evidence regarding safety effectiveness these populations. This study aims to describe the profile women early stage vaccination campaign Brazil. Methods an observational cross-sectional using data from Brazilian surveillance information system for adverse events (SI-EAPV) characterize available (Sinovac/Butantan, Pfizer/BioNTech, AstraZeneca Janssen) after...

10.1101/2021.12.14.21267777 preprint EN cc-by-nd medRxiv (Cold Spring Harbor Laboratory) 2021-12-17

Greece has a public universal health system, the National Health System (ESY) – with mandatory insurance coverage (IKA) for all working people (either employees or self-employed). On top of that, can voluntarily have private insurance. EOPYY (National Organisation Healthcare Provision) is only responsible party purchasing services funded by resources based on Social Security Fund (EFKA) contributions and state budget. There limited number drugs being exclusively provided care free (EOPYY...

10.30968/rbfhss.2022.131.0789 article EN cc-by-nc-nd Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde 2022-03-25

Abstract Several countries maintain universal health coverage, which implies responsibility to organize delivery formats of healthcare services and products for citizens. In Brazil, the system has a principle access more than 30 years, but many deficiencies remain country observes day practice those seeking judicial decisions determine provision healthcare.

10.1017/jme.2023.22 article EN The Journal of Law Medicine & Ethics 2022-01-01

Media Doctor Brazil: health news quality assessment Introduction:The Brazilian population is often exposed to information about new Health Technologies, which, in most cases, are incomplete, being possible favor or not treatments and technologies that implemented the market and, consequently, pose a risk health.The aim of this paper evaluate publications general public, published by media, including newspapers, magazines online publications. Methods:A cross-sectional study was conducted...

10.17648/rebrats-2019-113753 article EN Primeiro Congresso da REBRATS 2019-01-01

Introduction: Venous ulcers (UV) account for 80% of lower limb ulcers, affecting about 1% the world's population.Compressive socks are recommended to prevent a high rate (70% rate) these wounds.Objectives: To present scientific evidence on efficacy, effectiveness and safety related use compression stockings in prevention venous patients with chronic insufficiency CEAP C5.Methods: Evidence was performed Medline (PubMed), Embase, Lilacs Cochrane Library.A total 1,414 studies were identified,...

10.17648/rebrats-2019-113683 article EN Primeiro Congresso da REBRATS 2019-01-01

Voretigene neparvovec: the new gene therapy for eye diseases Introduction: Inherited retinal dystrophies associated with biallelic mutations in 65 kDa pigment epithelial (RPE65) are ocular that result gradual degeneration of photoreceptor cells located retina.Two types stand out: Retinitis Pigmentosa type 20 (RP20) and Leber congenital Amaurosis 2 (LCA2).Symptoms usually begin childhood range from poor visual acuity low light environments to total blindness.Currently, only treatment option...

10.17648/rebrats-2019-113675 article EN Primeiro Congresso da REBRATS 2019-01-01

Burosumab for treatment of patients with hypophosphatamic ricketsIntroduction: X-linked hypophosphatemia (HLX), which is a rare, permanent, chronically disabling and deforming bone disease, profound impact on the patient's daily activities quality life.XLH have

10.17648/rebrats-2019-113712 article EN Primeiro Congresso da REBRATS 2019-01-01
Coming Soon ...